Results 11 to 20 of about 1,874,188 (207)

Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy. [PDF]

PLoS Neglected Tropical Diseases, 2012
Mass vaccinations are a main strategy in the deployment of oral cholera vaccines. Campaigns avoid giving vaccine to pregnant women because of the absence of safety data of the killed whole-cell oral cholera (rBS-WC) vaccine. Balancing this concern is the
Ramadhan Hashim, Ahmed M Khatib, Godwin Enwere, Jin Kyung Park, Rita Reyburn, Mohammad Ali, Na Yoon Chang, Deok Ryun Kim, Benedikt Ley, Kamala Thriemer, Anna Lena Lopez, John D Clemens, Jacqueline L Deen, Sunheang Shin, Christian Schaetti, Raymond Hutubessy, Maria Teresa Aguado, Marie Paule Kieny, David Sack, Stephen Obaro, Attiye J Shaame, Said M Ali, Abdul A Saleh, Lorenz von Seidlein, Mohamed S Jiddawi   +24 more
doaj   +3 more sources

Oral cholera vaccine in cholera prevention and control, Malawi [PDF]

Bulletin of the World Health Organization, 2018
Problem With limited global supplies of oral cholera vaccine, countries need to identify priority areas for vaccination while longer-term solutions, such as water and sanitation infrastructure, are being developed. Approach In 2017, Malawi integrated oral cholera vaccine into its national cholera control plan. The process started with a desk review and
Mbangombe M, Pezzoli L, Reeder B, Kabuluzi S, Msyamboza K, Masuku H, Ngwira B, Cavailler P, Grandesso F, Palomares A, Beck N, Shaffer A, MacDonald E, Senbete M, Lessler J, Moore SM, Azman AS   +16 more
openaire   +3 more sources

Global oral cholera vaccine use, 2013-2018. [PDF]

Vaccine, 2020
Vaccination is a key intervention to prevent and control cholera in conjunction with water, sanitation and hygiene activities. An oral cholera vaccine (OCV) stockpile was established by the World Health Organization (WHO) in 2013. We reviewed its use from July 2013 to all of 2018 in order to assess its role in cholera control.
Pezzoli L, Oral Cholera Vaccine Working Group of the Global Task Force on Cholera Control.   +1 more
europepmc   +6 more sources

Review of oral cholera vaccines: efficacy in young children

Infection and Drug Resistance, 2011
Cristina Masuet Aumatell1, JM Ramon Torrell1, Jane N Zuckerman21International Health Centre, Preventive Medicine Department, Bellvitge Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; 2World Health Organization Collaborating Centre for ...
Masuet Aumatell C, Ramon Torrell JM, Zuckerman JN   +2 more
doaj   +1 more source

Oral Cholera Vaccine Development and Use in Vietnam

PLoS Medicine, 2014
Anna Lena Lopez et ses collègues donnent un aperçu de la situation du choléra au Vietnam et discutent de la façon dont un vaccin oral contre le choléra a été développé et utilisé dans le cadre d'une stratégie de santé publique contre la maladie.
Đặng Đức Anh, Anna Lena Lopez, Hung Thi Mai Tran, Nguyễn Văn Cường, Vu Dinh Thiem, Mohammad Ali, Jacqueline Deen, Lorenz von Seidlein, David A. Sack   +8 more
openaire   +5 more sources

Vaxchora: A Single-Dose Oral Cholera Vaccine

Annals of Pharmacotherapy, 2017
Objective: To review trials evaluating the efficacy and safety of Vaxchora, a reformulated, single-dose, oral, lyophilized Vibrio cholerae CVD 103-HgR vaccine for the prevention of travel-related cholera caused by V cholerae serogroup O1. Data Sources: A literature search was conducted using MEDLINE (1946 to January week 3, 2017) and EMBASE (1996 to ...
Adriana, Cabrera, Jayne E, Lepage, Karyn M, Sullivan, Sheila M, Seed   +3 more
openaire   +3 more sources

Post-licensure deployment of oral cholera vaccines: a systematic review [PDF]

Bulletin of the World Health Organization, 2014
Objective To describe and analyse the characteristics of oral cholera vaccination campaigns; including location, target population, logistics, vaccine coverage and delivery costs.
Stephen Martin, Anna Lena Lopez, Anna Bellos, Jacqueline Deen, Mohammad Ali, Kathryn Alberti, Dang Duc Anh, Alejandro Costa, Rebecca F Grais, Dominique Legros, Francisco J Luquero, Megan B Ghai, William Perea, David A Sack   +13 more
doaj   +2 more sources

Vaccination strategies to combat an infectious globe: Oral cholera vaccines

Journal of Global Infectious Diseases, 2011
Cholera is a substantial health burden in many countries in Africa and Asia, where it is endemic. It is as well responsible for ongoing epidemics in sub-Saharan Africa which are becoming greater in terms of frequency, extension, and duration.
Rosa M López-Gigosos, Elena Plaza, Rosa M Díez-Díaz, Maria J Calvo   +3 more
doaj   +3 more sources

Stockpiling oral cholera vaccine

Bulletin of the World Health Organization, 2012
Cholera is re-emerging as a threat on the global public health stage. The number of reported cases worldwide is back at the peak level observed two decades ago,1 new Vibrio cholerae strains have appeared and antimicrobial resistance has increased. Weak surveillance systems and the possibility of travel and trade sanctions contribute to widespread ...
Stephen Martin, Alejandro Costa, William Perea   +2 more
doaj   +3 more sources

Considerations for Oral Cholera Vaccine Use during Outbreak after Earthquake in Haiti, 2010−2011

Emerging Infectious Diseases, 2011
Oral cholera vaccines (OCVs) have been recommended in cholera-endemic settings and preemptively during outbreaks and complex emergencies. However, experience and guidelines for reactive use after an outbreak has started are limited. In 2010, after over a
Kashmira A. Date, Andrea Vicari, Terri B. Hyde, Eric D. Mintz, M. Carolina Danovaro-Holliday, Ariel Henry, Jordan W. Tappero, Thierry H. Roels, Joseph Abrams, Brenton T. Burkholder, Cuauhtémoc Ruiz-Matus, Jon Andrus, Vance Dietz   +12 more
doaj   +2 more sources